Alkem Laboratories Balance Sheet Health
Financial Health criteria checks 6/6
Alkem Laboratories has a total shareholder equity of ₹119.1B and total debt of ₹12.4B, which brings its debt-to-equity ratio to 10.4%. Its total assets and total liabilities are ₹171.2B and ₹52.1B respectively. Alkem Laboratories's EBIT is ₹23.1B making its interest coverage ratio -11.6. It has cash and short-term investments of ₹22.9B.
Key information
10.4%
Debt to equity ratio
₹12.36b
Debt
| Interest coverage ratio | -11.6x |
| Cash | ₹22.89b |
| Equity | ₹119.10b |
| Total liabilities | ₹52.07b |
| Total assets | ₹171.17b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 539523's short term assets (₹111.1B) exceed its short term liabilities (₹41.8B).
Long Term Liabilities: 539523's short term assets (₹111.1B) exceed its long term liabilities (₹10.3B).
Debt to Equity History and Analysis
Debt Level: 539523 has more cash than its total debt.
Reducing Debt: 539523's debt to equity ratio has reduced from 23.5% to 10.4% over the past 5 years.
Debt Coverage: 539523's debt is well covered by operating cash flow (158.1%).
Interest Coverage: 539523 earns more interest than it pays, so coverage of interest payments is not a concern.